Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

SELL
$0.63 - $1.59 $14,112 - $35,616
-22,400 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$1.27 - $2.42 $655 - $1,248
516 Added 2.36%
22,400 $28,000
Q3 2021

Nov 10, 2021

SELL
$2.15 - $3.82 $2,319 - $4,121
-1,079 Reduced 4.7%
21,884 $48,000
Q2 2021

Aug 06, 2021

BUY
$2.89 - $4.45 $10,042 - $15,463
3,475 Added 17.83%
22,963 $86,000
Q1 2021

May 13, 2021

BUY
$2.9 - $4.09 $3,442 - $4,854
1,187 Added 6.49%
19,488 $64,000
Q4 2020

Feb 12, 2021

BUY
$3.38 - $5.14 $2,744 - $4,173
812 Added 4.64%
18,301 $62,000
Q3 2020

Nov 13, 2020

BUY
$2.99 - $4.9 $35,425 - $58,055
11,848 Added 210.03%
17,489 $71,000
Q2 2020

Aug 06, 2020

BUY
$2.11 - $3.38 $1,544 - $2,474
732 Added 14.91%
5,641 $19,000
Q1 2020

May 11, 2020

BUY
$1.83 - $3.45 $1,824 - $3,439
997 Added 25.49%
4,909 $11,000
Q4 2019

Feb 11, 2020

SELL
$3.5 - $10.35 $780 - $2,308
-223 Reduced 5.39%
3,912 $14,000
Q3 2019

Nov 14, 2019

BUY
$7.03 - $9.7 $2,291 - $3,162
326 Added 8.56%
4,135 $34,000
Q2 2019

Aug 12, 2019

BUY
$7.36 - $11.26 $5,895 - $9,019
801 Added 26.63%
3,809 $33,000
Q1 2019

May 13, 2019

BUY
$9.08 - $11.84 $4,785 - $6,239
527 Added 21.24%
3,008 $32,000
Q4 2018

Feb 12, 2019

BUY
$6.39 - $16.99 $3,795 - $10,092
594 Added 31.48%
2,481 $22,000
Q3 2018

Nov 13, 2018

BUY
$16.52 - $24.82 $25,490 - $38,297
1,543 Added 448.55%
1,887 $32,000
Q2 2018

Aug 09, 2018

BUY
$14.31 - $21.75 $4,922 - $7,482
344 New
344 $7,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.